Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

On the mechanism of CD47 targeting in cancer.

Zhao XW, Matlung HL, Kuijpers TW, van den Berg TK.

Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):E2843; author reply E2844-5. doi: 10.1073/pnas.1209265109. Epub 2012 Aug 24. No abstract available.

PMID:
22923695
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Inhibitory signaling through signal regulatory protein-α is not sufficient to explain the antitumor activities of CD47 antibodies.

Soto-Pantoja DR, Miller TW, Frazier WA, Roberts DD.

Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):E2842; author reply E2844-5. doi: 10.1073/pnas.1205441109. Epub 2012 Aug 24. No abstract available.

PMID:
22923696
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.

Willingham SB, Volkmer JP, Gentles AJ, Sahoo D, Dalerba P, Mitra SS, Wang J, Contreras-Trujillo H, Martin R, Cohen JD, Lovelace P, Scheeren FA, Chao MP, Weiskopf K, Tang C, Volkmer AK, Naik TJ, Storm TA, Mosley AR, Edris B, Schmid SM, Sun CK, Chua MS, Murillo O, Rajendran P, Cha AC, Chin RK, Kim D, Adorno M, Raveh T, Tseng D, Jaiswal S, Enger PØ, Steinberg GK, Li G, So SK, Majeti R, Harsh GR, van de Rijn M, Teng NN, Sunwoo JB, Alizadeh AA, Clarke MF, Weissman IL.

Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6662-7. doi: 10.1073/pnas.1121623109. Epub 2012 Mar 26.

PMID:
22451913
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

High-Affinity SIRPα Variants Potentiate Antibody Therapy Efficacy.

[No authors listed]

Cancer Discov. 2013 Jul;3(7):716. doi: 10.1158/2159-8290.CD-RW2013-124. Epub 2013 Jun 6.

PMID:
23847342
[PubMed - indexed for MEDLINE]
5.

On the origin and function of immune 'self' recognition.

van den Berg TK.

Immunol Lett. 2010 Jan 18;128(1):24-5. doi: 10.1016/j.imlet.2009.09.013. Epub 2009 Oct 4. Review. No abstract available.

PMID:
19808051
[PubMed - indexed for MEDLINE]
6.

Blocking CD47 to stop tumor growth.

Harrington M.

Lab Anim (NY). 2012 Apr 19;41(5):111. doi: 10.1038/laban0512-111b. No abstract available.

PMID:
22517079
[PubMed - indexed for MEDLINE]
7.

Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway.

Matozaki T, Murata Y, Okazawa H, Ohnishi H.

Trends Cell Biol. 2009 Feb;19(2):72-80. doi: 10.1016/j.tcb.2008.12.001. Epub 2009 Jan 12. Review.

PMID:
19144521
[PubMed - indexed for MEDLINE]
8.

The CD47 pathway is deregulated in human immune thrombocytopenia.

Catani L, Sollazzo D, Ricci F, Polverelli N, Palandri F, Baccarani M, Vianelli N, Lemoli RM.

Exp Hematol. 2011 Apr;39(4):486-94. doi: 10.1016/j.exphem.2010.12.011. Epub 2011 Jan 4.

PMID:
21211546
[PubMed - indexed for MEDLINE]
9.

Immunology. Making macrophages eat cancer.

Kershaw MH, Smyth MJ.

Science. 2013 Jul 5;341(6141):41-2. doi: 10.1126/science.1241716. No abstract available.

PMID:
23828933
[PubMed - indexed for MEDLINE]
10.

Innate immune 'self' recognition: a role for CD47-SIRPalpha interactions in hematopoietic stem cell transplantation.

van den Berg TK, van der Schoot CE.

Trends Immunol. 2008 May;29(5):203-6. doi: 10.1016/j.it.2008.02.004. Epub 2008 Apr 3. Review.

PMID:
18394962
[PubMed - indexed for MEDLINE]
11.

The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications.

Chao MP, Weissman IL, Majeti R.

Curr Opin Immunol. 2012 Apr;24(2):225-32. doi: 10.1016/j.coi.2012.01.010. Epub 2012 Feb 4. Review.

PMID:
22310103
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

[Role of CD47 in hematologic malignancies].

Su GH, Zhao YL.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Dec;21(6):1631-4. doi: 10.7534/j.issn.1009-2137.2013.06.050. Review. Chinese.

PMID:
24370062
[PubMed - indexed for MEDLINE]
13.

Correlated expression of CD47 and SIRPA in bone marrow and in peripheral blood predicts recurrence in breast cancer patients.

Nagahara M, Mimori K, Kataoka A, Ishii H, Tanaka F, Nakagawa T, Sato T, Ono S, Sugihara K, Mori M.

Clin Cancer Res. 2010 Sep 15;16(18):4625-35. doi: 10.1158/1078-0432.CCR-10-0349. Epub 2010 Aug 12.

PMID:
20705613
[PubMed - indexed for MEDLINE]
Free Article
14.

Marker-of-self becomes marker-of-senescence.

Sosale N, Discher DE.

Blood. 2012 Jun 7;119(23):5343-4. doi: 10.1182/blood-2012-04-418608. No abstract available.

PMID:
22679336
[PubMed - indexed for MEDLINE]
Free Article
15.

Anticancer drugs: Cracking the combination.

Bordon Y.

Nat Rev Drug Discov. 2013 Jul;12(7):505. doi: 10.1038/nrd4071. No abstract available.

PMID:
23812266
[PubMed - indexed for MEDLINE]
16.

Tumour immunology: cracking the combination.

Bordon Y.

Nat Rev Immunol. 2013 Jul;13(7):469. doi: 10.1038/nri3481. Epub 2013 Jun 7. No abstract available.

PMID:
23743478
[PubMed - indexed for MEDLINE]
17.

Apoptosis: eating sensibly.

Gregory CD, Brown SB.

Nat Cell Biol. 2005 Dec;7(12):1161-3. No abstract available. Erratum in: Nat Cell Biol. 2006 Jan;8(1):100.

PMID:
16319968
[PubMed - indexed for MEDLINE]
18.

Phagocytic signaling: you can touch, but you can't eat.

Kinchen JM, Ravichandran KS.

Curr Biol. 2008 Jun 24;18(12):R521-4. doi: 10.1016/j.cub.2008.04.058.

PMID:
18579095
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

CD47-signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction.

Zhao XW, van Beek EM, Schornagel K, Van der Maaden H, Van Houdt M, Otten MA, Finetti P, Van Egmond M, Matozaki T, Kraal G, Birnbaum D, van Elsas A, Kuijpers TW, Bertucci F, van den Berg TK.

Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18342-7. doi: 10.1073/pnas.1106550108. Epub 2011 Oct 31.

PMID:
22042861
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Functional elements on SIRPalpha IgV domain mediate cell surface binding to CD47.

Liu Y, Tong Q, Zhou Y, Lee HW, Yang JJ, Bühring HJ, Chen YT, Ha B, Chen CX, Yang Y, Zen K.

J Mol Biol. 2007 Jan 19;365(3):680-93. Epub 2006 Oct 3.

PMID:
17070842
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk